Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritis.

Göschl L, Preglej T, Boucheron N, Saferding V, Müller L, Platzer A, Hirahara K, Shih HY, Backlund J, Matthias P, Niederreiter B, Hladik A, Kugler M, Gualdoni GA, Scheinecker C, Knapp S, Seiser C, Holmdahl R, Tillmann K, Plasenzotti R, Podesser B, Aletaha D, Smolen JS, Karonitsch T, Steiner G, Ellmeier W, Bonelli M.

J Autoimmun. 2019 Dec 26:102379. doi: 10.1016/j.jaut.2019.102379. [Epub ahead of print]

PMID:
31883829
2.

Treg cells in health and autoimmune diseases: New insights from single cell analysis.

Scheinecker C, Göschl L, Bonelli M.

J Autoimmun. 2019 Dec 17:102376. doi: 10.1016/j.jaut.2019.102376. [Epub ahead of print] Review.

PMID:
31862128
3.

Unreported Missense Mutation in the Dimerization Domain of ADA2 Leads to ADA2 Deficiency Associated with Severe Oral Ulcers and Neutropenia in a Female Somalian Patient-Addendum to the Genotype-Phenotype Puzzle.

Göschl L, Winkler S, Dmytrus J, Heredia RJ, Lagler H, Ramharter M, Scheinecker C, Bonelli M, Schmetterer K, Pickl WF, Grabmeier-Pfistershammer K, Hershfield MS, Boztug K, Förster-Waldl E, Gualdoni GA.

J Clin Immunol. 2019 Nov 4. doi: 10.1007/s10875-019-00700-w. [Epub ahead of print] No abstract available.

PMID:
31686313
4.

Treg cells in autoimmunity: from identification to Treg-based therapies.

Göschl L, Scheinecker C, Bonelli M.

Semin Immunopathol. 2019 May;41(3):301-314. doi: 10.1007/s00281-019-00741-8. Epub 2019 Apr 5. Review.

PMID:
30953162
5.

Peripheral nerve transfers change target muscle structure and function.

Bergmeister KD, Aman M, Muceli S, Vujaklija I, Manzano-Szalai K, Unger E, Byrne RA, Scheinecker C, Riedl O, Salminger S, Frommlet F, Borschel GH, Farina D, Aszmann OC.

Sci Adv. 2019 Jan 2;5(1):eaau2956. doi: 10.1126/sciadv.aau2956. eCollection 2019 Jan.

6.

CCR6 controls autoimmune but not innate immunity-driven experimental arthritis.

Bonelli M, Puchner A, Göschl L, Hayer S, Niederreiter B, Steiner G, Tillmann K, Plasenzotti R, Podesser B, Georgel P, Smolen J, Scheinecker C, Blüml S.

J Cell Mol Med. 2018 Nov;22(11):5278-5285. doi: 10.1111/jcmm.13783. Epub 2018 Aug 22.

7.

How does abatacept really work in rheumatoid arthritis?

Bonelli M, Scheinecker C.

Curr Opin Rheumatol. 2018 May;30(3):295-300. doi: 10.1097/BOR.0000000000000491. Review.

PMID:
29401118
8.

Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis.

Bonelli M, Göschl L, Blüml S, Karonitsch T, Hirahara K, Ferner E, Steiner CW, Steiner G, Smolen JS, Scheinecker C.

Rheumatology (Oxford). 2016 Apr;55(4):710-20. doi: 10.1093/rheumatology/kev403. Epub 2015 Dec 16.

PMID:
26672908
9.

Author Response: Analytic Formulas on Factors Determining the Safety and Efficacy in UV-Light-Sensitized Corneal Cross-Linking.

Laggner M, Pollreisz A, Schmidinger G, Byrne RA, Scheinecker C, Schmidt-Erfurth U, Chen YT.

Invest Ophthalmol Vis Sci. 2015 Sep;56(10):5742. doi: 10.1167/iovs.15-17718. No abstract available.

PMID:
26325412
10.

Correlation Between Multimodal Microscopy, Tissue Morphology, and Enzymatic Resistance in Riboflavin-UVA Cross-Linked Human Corneas.

Laggner M, Pollreisz A, Schmidinger G, Byrne RA, Scheinecker C, Schmidt-Erfurth U, Chen YT.

Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3584-92. doi: 10.1167/iovs.15-16508.

PMID:
26047045
11.

Blockade of co-stimulation in chronic inflammatory diseases.

Scheinecker C.

Wien Med Wochenschr. 2015 Jan;165(1-2):23-7. doi: 10.1007/s10354-014-0313-x. Epub 2014 Oct 1. Review.

PMID:
25271110
12.

Monocytic cell differentiation from band-stage neutrophils under inflammatory conditions via MKK6 activation.

Köffel R, Meshcheryakova A, Warszawska J, Hennig A, Wagner K, Jörgl A, Gubi D, Moser D, Hladik A, Hoffmann U, Fischer MB, van den Berg W, Koenders M, Scheinecker C, Gesslbauer B, Knapp S, Strobl H.

Blood. 2014 Oct 23;124(17):2713-24. doi: 10.1182/blood-2014-07-588178. Epub 2014 Sep 11. Erratum in: Blood. 2015 Feb 5;125(6):1049.

13.

CD4⁺CD25⁻Foxp3⁺ T cells: a marker for lupus nephritis?

Bonelli M, Göschl L, Blüml S, Karonitsch T, Steiner CW, Steiner G, Smolen JS, Scheinecker C.

Arthritis Res Ther. 2014 Apr 28;16(2):R104. doi: 10.1186/ar4553.

14.

Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis.

Bonelli M, Ferner E, Göschl L, Blüml S, Hladik A, Karonitsch T, Kiener HP, Byrne R, Niederreiter B, Steiner CW, Rath E, Bergmann M, Smolen JS, Scheinecker C.

Arthritis Rheum. 2013 Mar;65(3):599-607. doi: 10.1002/art.37787.

15.

A dynamic real time in vivo and static ex vivo analysis of granulomonocytic cell migration in the collagen-induced arthritis model.

Byrne R, Rath E, Hladik A, Niederreiter B, Bonelli M, Frantal S, Smolen JS, Scheinecker C.

PLoS One. 2012;7(4):e35194. doi: 10.1371/journal.pone.0035194. Epub 2012 Apr 18.

16.

Targeting TNF receptors in rheumatoid arthritis.

Blüml S, Scheinecker C, Smolen JS, Redlich K.

Int Immunol. 2012 May;24(5):275-81. doi: 10.1093/intimm/dxs047. Epub 2012 Mar 28. Review.

PMID:
22457216
17.

Regulatory T cells form stable and long-lasting cell cluster with myeloid dendritic cells (DC).

Herman S, Krenbek D, Klimas M, Bonelli M, Steiner CW, Pietschmann P, Smolen JS, Scheinecker C.

Int Immunol. 2012 Jul;24(7):417-26. doi: 10.1093/intimm/dxs039. Epub 2012 Feb 24.

PMID:
22366044
18.

Heme oxygenase-1 end-products carbon monoxide and biliverdin ameliorate murine collagen induced arthritis.

Bonelli M, Savitskaya A, Steiner CW, Rath E, Bilban M, Wagner O, Bach FH, Smolen JS, Scheinecker C.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1):73-8. Epub 2012 Mar 6.

PMID:
22325451
19.

Effects of 18β-Glycyrrhetinic acid in hTNFtg mice - a model of rheumatoid arthritis.

Puchner A, Hayer S, Niederreiter B, Hladik A, Blueml S, Bonelli M, Scheinecker C, Smolen J, Redlich K.

Wien Klin Wochenschr. 2012 Mar;124(5-6):170-6. doi: 10.1007/s00508-011-0103-z. Epub 2012 Jan 3.

PMID:
22210441
20.

Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) and CD99 are critical in lymphatic transmigration of human dendritic cells.

Torzicky M, Viznerova P, Richter S, Strobl H, Scheinecker C, Foedinger D, Riedl E.

J Invest Dermatol. 2012 Apr;132(4):1149-57. doi: 10.1038/jid.2011.420. Epub 2011 Dec 22. Erratum in: J Invest Dermatol. 2012 Jul;132(7):1938.

21.

Rheumatoid arthritis in 2010: from the gut to the joint.

Scheinecker C, Smolen JS.

Nat Rev Rheumatol. 2011 Feb;7(2):73-5. doi: 10.1038/nrrheum.2010.226. Review. No abstract available.

PMID:
21289609
22.

Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells.

Scheinecker C, Bonelli M, Smolen JS.

J Autoimmun. 2010 Nov;35(3):269-75. doi: 10.1016/j.jaut.2010.06.018. Epub 2010 Jul 16. Review.

PMID:
20638240
23.

Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis.

Blüml S, Binder NB, Niederreiter B, Polzer K, Hayer S, Tauber S, Schett G, Scheinecker C, Kollias G, Selzer E, Bilban M, Smolen JS, Superti-Furga G, Redlich K.

Arthritis Rheum. 2010 Jun;62(6):1608-19. doi: 10.1002/art.27399.

24.

Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions.

Kueng HJ, Manta C, Haiderer D, Leb VM, Schmetterer KG, Neunkirchner A, Byrne RA, Scheinecker C, Steinberger P, Seed B, Pickl WF.

FASEB J. 2010 May;24(5):1572-82. doi: 10.1096/fj.09-137281. Epub 2010 Jan 7.

25.

Treg and lupus.

Bonelli M, Smolen JS, Scheinecker C.

Ann Rheum Dis. 2010 Jan;69 Suppl 1:i65-66. doi: 10.1136/ard.2009.117135. Review.

PMID:
19995748
26.

Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.

Karonitsch T, Feierl E, Steiner CW, Dalwigk K, Korb A, Binder N, Rapp A, Steiner G, Scheinecker C, Smolen J, Aringer M.

Arthritis Rheum. 2009 May;60(5):1463-71. doi: 10.1002/art.24449.

27.

Tocilizumab.

Scheinecker C, Smolen J, Yasothan U, Stoll J, Kirkpatrick P.

Nat Rev Drug Discov. 2009 Apr;8(4):273-4. doi: 10.1038/nrd2863. No abstract available.

PMID:
19337270
28.

Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.

Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C.

J Immunol. 2009 Feb 1;182(3):1689-95.

29.

Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).

Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C.

Int Immunol. 2008 Jul;20(7):861-8. doi: 10.1093/intimm/dxn044. Epub 2008 May 9.

PMID:
18469329
30.

Cytokines as therapeutic targets: advances and limitations.

Scheinecker C, Redlich K, Smolen JS.

Immunity. 2008 Apr;28(4):440-4. doi: 10.1016/j.immuni.2008.03.005. Review.

31.

Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease.

Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, Schonthaler HB, Kenner L, Tschachler E, Wagner EF.

Arthritis Res Ther. 2008;10(1):201. doi: 10.1186/ar2338. Epub 2008 Jan 18. Review.

32.

Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.

Bonelli M, von Dalwigk K, Savitskaya A, Smolen JS, Scheinecker C.

Ann Rheum Dis. 2008 May;67(5):664-71. Epub 2007 Aug 29.

PMID:
17728327
33.

TNF-induced structural joint damage is mediated by IL-1.

Zwerina J, Redlich K, Polzer K, Joosten L, Krönke G, Distler J, Hess A, Pundt N, Pap T, Hoffmann O, Gasser J, Scheinecker C, Smolen JS, van den Berg W, Schett G.

Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11742-7. Epub 2007 Jul 3.

34.

Dickkopf-1 is a master regulator of joint remodeling.

Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G.

Nat Med. 2007 Feb;13(2):156-63. Epub 2007 Jan 21.

PMID:
17237793
35.

Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.

Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN.

Nature. 2006 Apr 13;440(7086):890-5.

PMID:
16612374
36.

Application of in vivo microscopy: evaluating the immune response in living animals.

Scheinecker C.

Arthritis Res Ther. 2005;7(6):246-52. Epub 2005 Oct 19. Review.

37.

Phenotypic and functional deficiencies of monocyte-derived dendritic cells in systemic lupus erythematosus (SLE) patients.

Köller M, Zwölfer B, Steiner G, Smolen JS, Scheinecker C.

Int Immunol. 2004 Nov;16(11):1595-604. Epub 2004 Sep 20.

PMID:
15381672
38.

Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node.

Scheinecker C, McHugh R, Shevach EM, Germain RN.

J Exp Med. 2002 Oct 21;196(8):1079-90.

39.

Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis.

Fritsch R, Eselböck D, Skriner K, Jahn-Schmid B, Scheinecker C, Bohle B, Tohidast-Akrad M, Hayer S, Neumüller J, Pinol-Roma S, Smolen JS, Steiner G.

J Immunol. 2002 Jul 15;169(2):1068-76.

40.

Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.

Scheinecker C, Zwölfer B, Köller M, Männer G, Smolen JS.

Arthritis Rheum. 2001 Apr;44(4):856-65.

41.

Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation.

Riedl E, Stöckl J, Majdic O, Scheinecker C, Knapp W, Strobl H.

Blood. 2000 Dec 15;96(13):4276-84.

PMID:
11110702
42.

Functional involvement of E-cadherin in TGF-beta 1-induced cell cluster formation of in vitro developing human Langerhans-type dendritic cells.

Riedl E, Stöckl J, Majdic O, Scheinecker C, Rappersberger K, Knapp W, Strobl H.

J Immunol. 2000 Aug 1;165(3):1381-6.

43.
44.

Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics.

Strobl H, Scheinecker C, Riedl E, Csmarits B, Bello-Fernandez C, Pickl WF, Majdic O, Knapp W.

J Immunol. 1998 Jul 15;161(2):740-8.

45.

Two different drug-induced pulmonary complications in a patient suffering from rheumatoid arthritis.

Leeb BF, Scheinecker C, Schweitzer H, Smolen JS.

Br J Rheumatol. 1998 May;37(5):586-7. No abstract available.

PMID:
9651097
46.

Analysis of myeloid-associated genes in human hematopoietic progenitor cells.

Bello-Fernández C, Matyash M, Strobl H, Scheinecker C, Knapp W.

Exp Hematol. 1997 Oct;25(11):1158-66.

PMID:
9328452
47.

MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.

Pickl WF, Majdic O, Fischer GF, Petzelbauer P, Faé I, Waclavicek M, Stöckl J, Scheinecker C, Vidicki T, Aschauer H, Johnson JP, Knapp W.

J Immunol. 1997 Mar 1;158(5):2107-15.

PMID:
9036955
48.

TGF-beta 1 dependent generation of LAG+ dendritic cells from CD34+ progenitors in serum-free medium.

Strobl H, Riedl E, Scheinecker C, Bello-Fernandez C, Pickl WF, Majdic O, Knapp W.

Adv Exp Med Biol. 1997;417:161-5. No abstract available.

PMID:
9286354
49.

Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.

Pickl WF, Majdic O, Kohl P, Stöckl J, Riedl E, Scheinecker C, Bello-Fernandez C, Knapp W.

J Immunol. 1996 Nov 1;157(9):3850-9.

PMID:
8892615
50.

TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors.

Strobl H, Riedl E, Scheinecker C, Bello-Fernandez C, Pickl WF, Rappersberger K, Majdic O, Knapp W.

J Immunol. 1996 Aug 15;157(4):1499-507.

PMID:
8759731

Supplemental Content

Loading ...
Support Center